Late Recurrence of Low-Risk Stage II Colorectal Cancer Shortly After Etanercept
J Gastrointest Cancer
.
2016 Dec;47(4):506-508.
doi: 10.1007/s12029-015-9788-y.
Authors
Tony Ibrahim
1
,
Khalil Saleh
2
,
Viviane Track-Smayra
3
,
Nelly Ziade
4
,
Dalia Sarraf
5
,
Charbel Yazbeck
6
,
Nadine Khalife
2
,
Fadi Nasr
2
Affiliations
1
Hematology Oncology Department Saint Joseph University, Beirut, Lebanon. ibrahim_toni@hotmail.com.
2
Hematology Oncology Department Saint Joseph University, Beirut, Lebanon.
3
Pathology Department Faculty of Medicine Saint Joseph University, Beirut, Lebanon.
4
Rheumatology Department Faculty of Medicine Saint Joseph University, Beirut, Lebanon.
5
Radiology Department Faculty of Medicine Saint Joseph University, Beirut, Lebanon.
6
Gastroenterology and Hepatology Department Faculty of Medicine Saint Esprit Kaslik, Beirut, Lebanon.
PMID:
26691174
DOI:
10.1007/s12029-015-9788-y
No abstract available
Publication types
Case Reports
MeSH terms
Aged
Colorectal Neoplasms / drug therapy*
Etanercept / administration & dosage
Etanercept / therapeutic use*
Humans
Male
Neoplasm Staging
Recurrence
Substances
Etanercept